Please upgrade your browser.
Elementary-age girls who spend at least 70 minutes per week in phys ed consistently do better on standardized reading and math tests than girls who spend less than 35 minutes.
The surgical and medical treatment of renal cell carcinoma (RCC) has changed dramatically in the last several years and continues to constantly evolve.
There is information and assistance for patients, survivors, and caregivers on this website. Your participate is welcome. There is no charge for membership.
Designed to thwart blood vessel growth in tumors
The worldwide effort to find cures for rare disease is often the work of small organizations such as the the Myrovlytis Trust, a not-for-profit organization in Great Britain dedicated to finding treatments and cures for rare diseases. John Solly, charity manager for the Myrovlytis Trust, talks with host Dr. Bruce Bloom, the rationale for focusing large dollars on diseases affecting a small population and how the Trust is approaching the search for a cure to their first target disease, Birt-Hogg-Dubé Syndrome.
The American Cancer Society, which has long been a staunch defender of most cancer screening, is now saying that the benefits of detecting many cancers, especially breast and prostate, have been overstated.
Metastatic renal cell carcinoma (RCC) has poor outcomes. Metastatic disease is resistant to radiation therapy and chemotherapy, although some cases respond to immunotherapy. Although targeted cancer therapies have improved progression-free survival for RCC they have not yet demonstrated much improvement in overall survival. What next after failure of these drugs?
|Powered by NeonCRM|